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Abstract: Background: Elevated intracranial pressure (ICP) occurs 18–24 h after ischaemic stroke
and is implicated as a potential cause of early neurological deterioration. Increased resistance to
cerebrospinal fluid (CSF) outflow after ischaemic stroke is a proposed mechanism for ICP eleva-
tion. Ultra-short duration hypothermia prevents ICP elevation 24 h post-stroke in rats. We aimed
to determine whether hypothermia would reduce CSF outflow resistance post-stroke. Methods:
Transient middle cerebral artery occlusion was performed, followed by gradual cooling to 33 ◦C.
At 18 h post-stroke, CSF outflow resistance was measured using a steady-state infusion method.
Results: Hypothermia to 33 ◦C prevented ICP elevation 18 h post-stroke (hypothermia ∆ICP = 0.8
± 3.6 mmHg vs. normothermia ∆ICP = 4.4 ± 2.0 mmHg, p = 0.04) and reduced infarct volume
24 h post-stroke (hypothermia = 78.6 ± 21.3 mm3 vs. normothermia = 108.1 ± 17.8 mm3; p = 0.01).
Hypothermia to 33 ◦C did not result in a significant reduction in CSF outflow resistance compared
with normothermia controls (0.32 ± 0.36 mmHg/µL/min vs. 1.07 ± 0.99 mmHg/µL/min, p = 0.06).
Conclusions: Hypothermia treatment was protective in terms of ICP rise prevention, infarct volume
reduction, and may be implicated in CSF outflow resistance post-stroke. Further investigations are
warranted to elucidate the mechanisms of ICP elevation and hypothermia treatment.
Keywords: hypothermia; cerebrospinal fluid; outflow resistance; ischaemia; intracranial pressure;
stroke
1. Introduction
We have previously demonstrated that there is a damaging, transient increase in
intracranial pressure (ICP) occurring 18–24 h post-stroke in rats [1–6]. Evidence suggests
that ICP elevation has detrimental consequences on stroke outcome and may cause delayed
expansion of the infarct core into the penumbral region. Penumbral tissue is maintained
by perfusion from the leptomeningeal collaterals following stroke [7–9]. The disruption
of autoregulatory mechanisms during stroke results in cerebral perfusion pressure (CPP)
becoming the driving force of this collateral perfusion. ICP is directly related to CPP as
CPP is the difference in pressure between ICP and mean arterial pressure. We have shown
that an increase in ICP causes a reduction in CPP and results in reduced flow through the
leptomeningeal collateral vessels [3,10]. Short-duration hypothermia is a potential therapy
and has previously been shown to prevent this elevated pressure following experimental
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stroke [1,2,4]. Our understanding of the mechanism of ICP elevation is incomplete, thus the
mechanism of how hypothermia works to prevent ICP elevation is not clear and warrants
investigation.
The Monroe–Kellie doctrine [11,12] describes ICP as the pressure that exists within
the craniospinal compartment, and states that this compartment is a closed system which
comprises a fixed volume. This volume is composed of blood, brain tissue and CSF within
the skull. Normally, the system can compensate when there is an increase in the volume
of one component of the compartment by decreasing the volume of one of the other
components. However, when this compensatory mechanism fails, it results in increases
in ICP. This suggests that the mechanisms responsible for ICP elevation derive from an
increase in volume in one or more of the components of the craniospinal compartment.
Our group have previously demonstrated that the dramatic increases in ICP observed at
24 h in rats following ischaemic stroke is not primarily driven by oedema [2]. Additionally,
unpublished data from our group have also shown that increased cerebral blood volume
does not contribute to ICP elevation post-stroke. These findings suggest that CSF volume
is the likely driver of ICP elevation, and this observation has been backed by preliminary
data from our group [6] and reproduced by others [13].
CSF volume can be altered in the craniospinal space by two pathways; increased CSF
production and decreased CSF outflow, both of which would result in an overall increase in
the volume of CSF within the compartment. CSF volume is very difficult to quantify in vivo
but we are able to determine insights into CSF dynamics by measuring CSF production or
CSF outflow resistance (resistance to the efflux of CSF out of the craniospinal compartment)
in real time. Previous work from our group has demonstrated that there is an increase
in CSF outflow resistance in rats subjected to cortical stroke compared with sham rats
18 h post-stroke [6]. A recent study by Alshuhri et al., using an indirect estimation of CSF
production at 24 h post-stroke, could not detect an increase in CSF production in stroke
animals compared with sham [13]. These results suggest that CSF outflow resistance may
be an important component that contributes to increased CSF volume, and therefore is
implicated in ICP elevation.
We have previously demonstrated that ultra-short duration hypothermia, using clin-
ically relevant cooling rates, prevents ICP elevation and reduces infarct volume 24 h
post-stroke in rats [14]. If the main driver of ICP elevation post-stroke is due to an increase
in CSF outflow resistance, it is plausible that hypothermia would decrease CSF outflow
resistance and lead to reduced ICP elevation post-stroke in hypothermia animals compared
to normothermia controls. We aimed to investigate whether ultra-short duration hypother-
mia using clinically relevant cooling rates reduces CSF outflow resistance 18 h following
experimental stroke, when compared with normothermia controls.
2. Materials and Methods
2.1. Animals
Adult male (11–12 weeks old) outbred Wistar rats (n = 32, Animal Services Unit,
University of Newcastle, Callaghan, Australia) weighing 280–350 g were used for this
study. Animals were housed under standard conditions in a 12 h light-dark cycle with
unlimited access to food and water. All experimental procedures were in accordance with
the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and
were approved by the Animal Care and Ethics Committee of the University of Newcastle
(A-2013-343 and A-2020-003).
2.2. Anaesthesia and Physiological Monitoring
Rats were anesthetized with isoflurane (5% induction, 2–2.5% maintenance) in 50:50
N2:O2. Incision sites were cleaned and injected subcutaneously (s.c.) with 2 mg/kg 0.05%
Bupivacaine (Pfizer, Sydney, Australia). Body temperature was regulated throughout
the surgery with a rectal temperature thermocouple (RET-2, Physitemp Instruments Inc.,
Clifton, NJ, USA). The femoral artery was cannulated with a catheter (1 and 2 French
Brain Sci. 2021, 11, 1589 3 of 10
silicone tubing) for continuous monitoring of arterial blood pressure and heart rate. Af-
ter stroke surgery and hypothermia treatment, rectal paracetamol (250 mg/kg, Glaxo-
SmithKline, Brentford, UK) was administered for overnight pain relief. Saline injections
(2 × 1.5 mL, s.c.) were also given to prevent dehydration and animals were returned to
their cages with free access to softened laboratory chow and water.
2.3. Implantation of Datalogger Device
Datalogger implantation was performed for continuous monitoring of core body
temperature during experimental protocols and recovery. Implantation was performed
according to previously described methods [15]. To summarise, a 2 cm longitudinal skin in-
cision was made in the lateral lower right abdominal quadrant to expose the subcutaneous
space at the ventral thigh crease. A subcutaneous pocket was created using haemostats and
forceps. The pocket was made large enough to hold the temperature monitoring datalogger
(Maxim, San Jose, CA, USA). The pocket was secured by closing the skin incision with 4-0
nylon sutures.
2.4. Intracranial Pressure and Laser Doppler Measurement
Cranial surgery was performed according to previously described methods [16]. To
summarise, the ICP probe (OpSens Fibre Optic Pressure Sensors, Opsens Solutions, Quebec
City, QC, Canada) was inserted epidurally into a saline filled, polyether ether ketone
(PEEK) screw (Bregma 7 mm posterior and 2 mm lateral) in the left parietal bone. The
Laser Doppler probe (Moor Instruments, Devon, UK) was inserted into a second hollow
PEEK screw (Bregma 2 mm posterior and 5 mm lateral) in the right parietal bone. Lastly,
a third PEEK screw was placed over the lateral ventricle (Bregma 0.8 mm posterior and
2 mm lateral) to be used for infusion of artificial CSF (aCSF). The screws were secured with
dental cement and an airtight seal was created around each probe using a caulking material
(Silagum, DMG Chemisch-Pharmazeutische, Hamburg, Germany). Correct placement of
the ICP probe was confirmed by a response to abdominal compression which was observed
on both ICP and arterial blood pressure waveforms. ICP was monitored at pre-stroke
baseline and again at 18 h post-stroke: prior to, during and after aCSF infusion until 24 h
post-stroke (Figure 1). Tissue perfusion via Laser Doppler flowmetry (LDF) was measured
at baseline and throughout the stroke surgery and hypothermia treatment/normothermia.
To account for any variation in baseline ICP between groups, change in ICP from baseline
to 18 h post stroke (∆ICP) was used for all ICP analyses.









































Figure 1. Experimental protocol in hours. MAP = Mean arterial pressure. The asterisk (*) indicates
the period of baseline ICP readings for 30 min.
2.5. Middle Cerebral Artery Occlusion
Transient middle cerebral artery occlusion (MCAo) was carried out according to
our established protocol [17,18]. To summarise, a 7 cm length of monofilament nylon
suture with a silicon tip (3 mm length × 0.38 mm O.D silicone) was inserted through the
ligated right external carotid artery into the right internal carotid artery. The filament was
advanced 20 mm through the internal carotid artery until resistance was felt, and a drop in
perfusion units (>50% drop from baseline) on the LDF was observed which indicated that
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the middle cerebral artery has been occluded. Reperfusion was achieved at 2 h post-MCAo
by retracting the monofilament through the internal carotid artery approximately 18 mm
until the silicone tip was visible in the external carotid artery stump.
2.6. Hypothermia Treatment
We opted for the gradual cooling hypothermia paradigm as opposed to the traditional
rapid cooling techniques that are common in pre-clinical literature. This choice was
based on previous findings that show that clinically relevant cooling rates prevent ICP
elevation and reduce infarct volume [14]. Using this paradigm allows us to make greater
assumptions about the clinical translatability of hypothermia and its mechanisms that
prevent ICP elevation post-stroke. Animals were randomized to hypothermia treatment or
normothermia control immediately after MCAo. Hypothermia was initiated 1 h after vessel
occlusion. Animals were cooled gradually at a rate of 2 ◦C/h to a target core temperature
of 33 ◦C [15]. Once target temperature was reached, animals were maintained at target for
30 min. No external cooling was necessary as anaesthesia prevented normal regulation of
core body temperature. For recovery and rewarming, core body temperature was increased
to 35 ◦C prior to recovery from anaesthesia, and animals were placed in a cage half over a
warming pad (Passwell, Glen Osmond, Australia) to allow for self-thermoregulation, per
our established technique [14]. Animals in the normothermia group were kept at 37 ◦C for
the duration of this period.
2.7. Artificial Cerebrospinal Fluid (aCSF) Infusion
CSF outflow resistance was calculated using a steady-state infusion method [19,20]
with some modifications. To summarise, a catheter was inserted into the PEEK screw
located over the contralateral lateral ventricle. The catheter was inserted 9 mm into the
ventricle and secured to the screw using caulking material (Silagum, DMG Chemisch-
Pharmazeutische, Hamburg, Germany). Baseline ICP was monitored for 30 min prior
to infusion of aCSF (Harvard Apparatus, Holliston, MA, USA), which commenced at
18 h post-stroke. The aCSF infusion was carried out using a syringe driver (Harvard
Apparatus, Holliston, MA, USA). The infusion rate was adjusted incrementally, starting
from 5 µL/min, then increasing to 10, 15, 20, 25 and 30 µL/min. A 5–10 min period was
allowed for a steady-state ICP to be established after each increase. Infusion was stopped
once ICP reached 40 mmHg, or after 10 min at 30 µL/min, whichever occurred sooner. This
variability in the protocol was necessary to allow for inter-animal differences while also
taking animal welfare considerations into account. An investigator blinded to treatment
allocation made all decisions relating to the aCSF infusion protocol.
2.8. Histological Analysis
Animals were euthanized at 24 h post-stroke. They were transcardially perfused
with saline. Brains were removed and sliced into 2 mm sections on a rat brain matrix.
Tryphenyltetrazolium chloride (TTC) staining was performed to confirm the presence of
ischaemic stroke by identification of infarcted tissue. These same brains were then fixed in
neutral-buffered formalin before processing for haematoxylin and eosin (H&E) staining
for infarct volume quantification. Images were scanned using a high-resolution scanner
(Aperio, Vista, CA, USA) and infarct volumes were analyzed using the Aperio ImageScope
program. Infarct analysis was conducted by an independent investigator blinded to
treatment allocation. Infarct volumes were corrected for oedema by applying the formula:
corrected infarct volume (mm3) = infarct volume × (contralateral volume/ipsilateral
volume) [2].
2.9. Exclusion Criteria and Statistical Analyses
Subarachnoid haemorrhage, equipment malfunction and lack of sufficient LDF drop at
occlusion were pre-specified exclusion criteria. For outflow resistance measurements, lack
of reliable ICP trace and complications during aCSF infusion that prevented ICP readings
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from at least 4 infusion rates, were also prespecified exclusions. Sample sizes were based
on a similar study [13] which calculated that 6 animals per group were required to detect a
60% difference in CSF outflow resistance between groups, with standard settings of alpha
0.05, power 0.8. Statistical analyses were performed using GraphPad Prism version 9.0.
Data were tested for normal distribution using the Shapiro–Wilk normality test. Two-
tailed Student’s t-test (unpaired) were used to compare differences between hypothermia
treatment and normothermia control groups. Relationships were determined by Pearson r
correlation. Data are presented as mean ± standard deviation (SD) unless otherwise stated.
Statistical significance was accepted at the level of p < 0.05.
3. Results
A total of 15 animals were included in this study: 9 treated with hypothermia to
33 ◦C and 6 normothermia controls. A total of 17 animals were excluded. Reasons for
exclusion were lack of sufficient LDF drop at occlusion (n = 4), abnormal animal physiology
(n = 1), death during aCSF infusion (n = 1), poor oxygenation post-surgical intervention
(n = 3), subdural bleed during cranial surgery (n = 1), surgical error during MCAo (n = 1),
death at reperfusion with no clear cause detected at post-mortem (n = 1), subarachnoid
haemorrhage confirmed at post-mortem (n = 2), overnight death with no apparent cause
detected at post-mortem (n = 1), and ICP equipment malfunction (n = 2). One animal in
the hypothermia group experienced a fever overnight, which may have contributed to an
ICP rise in this animal. The animal was included in all analyses, as fever complication
was not a pre-specified exclusion criterion. Three animals had infusions stopped before
the 30 µL/min infusion rate was reached, because an ICP level of 40 mmHg was reached.
These animals were included in all analyses.
3.1. Normality Tests
The Shapiro–Wilk normality test indicated that ICP, outflow resistance and infarct
volume variables were normally distributed {∆ICP (hypothermia: W = 0.96, p = 0.80 and
normothermia: W = 0.89, p = 0.34), outflow resistance (hypothermia: W = 0.87, p = 0.14 and
normothermia: W = 0.82, p = 0.09) and infarct volume (hypothermia: W = 0.98, p = 0.98 and
normothermia: W = 0.99, p = 0.99)}.
3.2. ICP Elevation and Infarct Volume
Accurate temperature regulation was maintained in hypothermia treated animals
and normothermia controls (Figure 2A). Mean temperature was 33.0 ± 0.7 ◦C during
hypothermia treatment and 37.2 ± 1.0 ◦C during the equivalent normothermia period.
Target temperature was achieved after a mean of 92.2 ± 31.5 min from hypothermia
initiation. ∆ICP was significantly higher in the normothermia group vs. the hypothermia
treatment group (4.4 ± 2.3 mmHg vs. 0.8 ± 3.6 mmHg, p = 0.04: Figure 2B). Normothermia
animals had significantly larger infarct volumes compared with hypothermia treated
animals (108.1 ± 17.8 mm3 vs. 78.6 ± 21.3 mm3, p = 0.01: Figure 2C). Representative images
of infarct size are shown in Figure 3.
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Figure 2. (A) Core temperature recordings during hypothermia and equivalent normothermia period.
0–2 h represent period of occlusion. Hypothermia treatment was initiated at 1 h. (B) ∆ICP from
baseline to 18 h in the hypothermia treated and normothermia control animals. (C) Infarct volumes
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Figure 3. Representative H&E-stained brain sections of (A) normothermia and (B) hypothermia
treated animals. Red line indicates area of infarction. Scale bar = 4 mm.
3.3. CSF Outflow Resistance
CSF outflow resistance (Rout) was not significantly different between normothermia
cont ols and hypothermia treated animals 18 h post-stroke (1.1 ± 1.0 mmHg/µL/min vs.
0.3 ± 0.4 mHg/µL/min, p = 0.06: Figure 4A). Ther was no correlation between outflow
resistance and ∆ICP at 18 h in hypothermia treated animals (r2 = 0.04, p = 0.61: Figure 4B)
or normothermia control animals (r2 = 0.09, p = 0.56: Figure 4B).
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Figure 4. (A) Rout values between hypothermia treated and normothermia controls. (B) Pearson
correlation between ∆ICP and Rout in hypothermia animals (r2 = 0.04, p = 0.61: white circles) and
nor other i animals (r2 = 0.09, p = 0.56: black squares).
4. Discussion
We have confirmed previous work indicating that clinically achievable gradual cool-
ing effectively prevents ICP elevation and reduces infarct volume post-stroke. We also
demonstrated a trend to a physiologically relevant difference in CSF outflow resistance
between hypothermia treated animals and normothermia controls 18 h post-stroke. These
data suggest that, at least in part, hypothermia cytoprotection may act via reduction of
CSF outflow resistance, preventing ICP elevation, and thereby maintaining penumbral
perfusion by prevention of failure of leptomeningeal collateral flow.
In our previous study, ICP and infarct volume were measured at 24 h [14]. In this
present study, ICP was measured at 18 h post-stroke, prior to aCSF infusion, and infarct
volume was assessed at 24 h post-stroke. The earlier ICP time point was necessary to
conduct the infusion of aCSF and measure outflow resistance prior to the occurrence of
any significant ICP rises. Interestingly, we found that ∆ICP at 18 h post-stroke was already
significantly greater in normothermia animals compared to hypothermia treated animals.
It has been shown that ICP elevation peaks 24 h post-stroke [1,2,4] but recent work by our
group has demonstrated significant ICP rises as early as 18 h post-stroke [6,21]. Therefore,
these data provide further evidence in favor of hypothermia treatment and its profound
effect on ICP, as early as 18 h post-stroke.
Our results suggest that hypothermia treatment may influence CSF outflow post-
stroke, with animals treated with hypothermia having lower outflow resistance rates than
normothermia controls, albeit not statistically significant. The recent study by Alshuhri
et al. [13] demonstrated that there is a significant increase in CSF outflow resistance in stroke
rats subjected to permanent MCAo compared to sham control rats. Their data indicated
that CSF outflow r sistance, rather than oed ma, was the mechanism responsible for ICP
elevation following ischaemic stroke. We have sho n pr viously that hypothermia results
in a sustained prevention of ICP elevation po t-stroke [1,2,4]. We have also shown that
hypothermia has a powerful effect on infarct volume r duction [1,2]. The results btained
in this present study suggest that outflow resistance may be a mechanism inv lved in
ICP elevatio , and that hypo ermia may act on this mechanism. The difference obtained
in Rout between treatment and control groups was very nearly statistically significant
(p = 0.06), a d if tru , would be of physiological relevance. It is l kely that ICP amplifies
the effects of many hours of change in the balance between CSF production and outflow
resistance. Therefore, what may seem to be minor differences in the outflow resistance
rates between groups may result in quite significant differences when measured over a
longer time scale.
Our results suggest that the involvement of CSF outflow resistance as a mechanism
for ICP elevation cannot be discarded, however it is important to note that it may not be
the only mechanism responsible for this pressure rise post-stroke. CSF production is the
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other compartment of CSF dynamics that influences the volume of CSF in the craniospinal
compartment at any given time. An indirect estimation of CSF production rates by others
could not detect an increase in CSF production post-stroke [13]. Therefore, it is possible
that hypothermia treatment reduces resistance to CSF outflow but may also act on CSF
production mechanisms to further reduce the rate of production post-stroke. Reduced CSF
production rates have been demonstrated with lower body temperatures [22–24], however
this has not been examined in the context of ischaemic stroke. It is also not yet known
whether the effect is sustained following rewarming. One of the remarkable attributes of
the prevention of ICP rise with hypothermia treatment in these studies is that it is seen
many hours after rewarming, indicating a longer term, switch-like mechanism of body
cooling. Hypothermia may therefore have a synergistic effect on CSF dynamics, altering
both outflow resistance and production mechanisms to cause an overall reduction in CSF
volume ultimately preventing ICP elevation.
Another possible mechanism of interest relates to the glymphatic system. Glymphatic
circulation drives CSF into the brain along periarterial spaces and drives interstitial fluid
out [25]. This fluid may exit via perivenous spaces but there is also evidence to suggest
the involvement of intramural periarterial drainage (IPAD) [26,27]. It is likely that IPAD
plays an important role in the clearance of large molecules, however its contribution to the
clearance of water and ions remains unknown. While the mechanisms of CSF clearance do
not pertain to this present study, glymphatic dysfunction has been reported in stroke [28],
and its contribution could therefore be important if glymphatic circulation is found to play
a significant role in CSF outflow.
It is also possible that hypothermia may prevent post-stroke ICP rise by mechanisms
unrelated to CSF dynamics. A recent study by Kalisvaart et al. [29] suggests that tissue
compliance may be an important adaptive response against elevated ICP. The study as-
sessed neuronal volume and morphology in several brain regions following stroke-induced
brain injury in rats and demonstrated that widespread tissue and cell shrinkage occurs
24 h post-stroke in brain areas that were outside of the injury site. These findings may
have important implications regarding the mechanistic actions of hypothermia to prevent
ICP elevation post-stroke. Perhaps tissue compliance may be further altered following
hypothermia treatment, and it is this cell volume reduction that aids in buffering elevated
ICP.
We have demonstrated that gradual cooling successfully prevents ICP elevation, re-
duces infarct volume post-stroke, and has a role in reducing CSF outflow resistance. A
limitation of this study relates to the animal variability in the CSF outflow analysis. An-
other limitation of this study is the choice of anaesthetic used. Previous studies have
reported that anaesthesia can alter responses in CSF flow [25] and have suggested the use
of ketamine/xylazine as the preferred choice in studies investigating CSF [30]. Isoflurane
anaesthesia was used here in order to match the design of previous studies investigating
CSF outflow resistance and ICP [6,13]. Moreover, the long duration of the experimental
procedure made isoflurane a more convenient option than other alternatives. Another
limitation relates to the time point of CSF outflow resistance measurements. Our time point
was chosen to enable us to confirm ICP elevation in normothermia animals. However,
outflow resistance would need to be increased for some time, and at constant CSF produc-
tion rates, before ICP begins to rise. By the time of peak ICP at 24 h, outflow resistance
presumably has already renormalized. So, the optimal time point for infusion of aCSF to
measure outflow resistance is likely earlier than the 18 h post-stroke time point used in this
study. Future work should therefore be done in the absence of significant ICP elevation in
both groups, which should provide a more informed investigation into the relationship
between hypothermia, CSF outflow resistance, and ICP.
5. Conclusions
In conclusion, our results suggest that hypothermia treatment has important effects on
CSF volume dynamics. CSF outflow resistance has been implicated as a mechanism for ICP
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elevation following experimental stroke. Moreover, hypothermia treatment has routinely
been shown to prevent this ICP rise, suggesting hypothermic cerebroprotection acts directly
on this mechanism. Having a mechanistic understanding of how hypothermia prevents
ICP elevation is crucial if the treatment is to be translated to stroke patients. Therefore,
these results are the first steps towards elucidating the mechanism involved in intracranial
pressure elevation and hypothermia treatment following experimental stroke.
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